Home » Court Allows Novartis to Amend Diovan Patent
Court Allows Novartis to Amend Diovan Patent
Novartis AG has won court approval to amend a Singapore patent for its top-selling blood pressure drug, Diovan, bringing it a step closer to fending off moves by a Malaysian unit of Indian drugmaker Ranbaxy to invalidate the patent.
Business Times
Business Times
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May